AMBOSS Profile picture
Empowering all doctors to provide the best possible care. Free trial 👉 https://t.co/84gYhWexam Privacy policy 👉 https://t.co/FNt5UZ8y2P
Apr 13, 2023 8 tweets 3 min read
1/In this RCT, continuous IV hydrocortisone significantly lowered the risk of death in patients with severe CAP compared to placebo. Welcome to our weekly #OMTweetorial. #MedTwitter #MedEd #EBM #JournalClub Image 2/In this pre-COVID government-funded trial in @NEJM, Pierre-François Dequin et al assessed whether a continuous hydrocortisone infusion reduced mortality in patients with severe CAP.